The effects of UVB on ORAI1 channel and the role of ORAI1 channel on the UVB-induced epidermal hyperplasia and upregulation of TSLP and COX-2 by �삤�듅以�
  
저작자표시-비영리-변경금지 2.0 대한민국 
이용자는 아래의 조건을 따르는 경우에 한하여 자유롭게 
l 이 저작물을 복제, 배포, 전송, 전시, 공연 및 방송할 수 있습니다.  
다음과 같은 조건을 따라야 합니다: 
l 귀하는, 이 저작물의 재이용이나 배포의 경우, 이 저작물에 적용된 이용허락조건
을 명확하게 나타내어야 합니다.  
l 저작권자로부터 별도의 허가를 받으면 이러한 조건들은 적용되지 않습니다.  
저작권법에 따른 이용자의 권리는 위의 내용에 의하여 영향을 받지 않습니다. 
이것은 이용허락규약(Legal Code)을 이해하기 쉽게 요약한 것입니다.  
Disclaimer  
  
  
저작자표시. 귀하는 원저작자를 표시하여야 합니다. 
비영리. 귀하는 이 저작물을 영리 목적으로 이용할 수 없습니다. 
변경금지. 귀하는 이 저작물을 개작, 변형 또는 가공할 수 없습니다. 
The effects of UVB on ORAI1 channel 
and the role of ORAI1 channel on 
the UVB-induced epidermal 
hyperplasia and upregulation of 
TSLP and COX-2
Seung Joon Oh
Department of Medicine
The Graduate School, Yonsei University
The effects of UVB on ORAI1 channel 
and the role of ORAI1 channel on 
the UVB-induced epidermal 
hyperplasia and upregulation of 
TSLP and COX-2
Directed by Professor Seung Hun Lee
The Master’s Thesis
submitted to the Department of Medicine,
the Graduate School of Yonsei University
in partial fulfillment of the requirements for the 
degree of Master of Medical Science
Seung Joon Oh
December 2015

ACKNOWLEDGEMENTS
The final outcome of this study required much guidance and 
inspiration from Professor Seung Hun Lee. I would like to 
express my great appreciation to her for her support and 
encouragement along the completion of this thesis. 
I also owe my profound gratitude to Professor Kyung Hee 
Chun and Professor Sang Eun Lee who took keen interest on 
this study and offered invaluable professional advices and 
guidance.
I specially thank to Song-Ee Kim for her kind advices and 
encouragement. 
Last but not least, I thank my family for their unchanging 
presence in my life.
Seung Joon Oh
TABLE OF CONTENTS
ABSTRACT ........................................................................................1
I. INTRODUCTION............................................................................3
II. MATERIALS AND METHODS.....................................................7
1. Cell culture and treatments ...........................................................7
2. Mice and treatments......................................................................8
3. Quantification of epidermal thickness and hyperplasia..................9
4. Immunohistochemical staining .....................................................9
5. Quantitative PCR for mRNA expression.....................................10
6. Western blotting .........................................................................11
III. RESULTS....................................................................................13
1. Upregulation of ORAI1 expression by UVB in mouse skin.........13
2. UVB-induced epidermal hyperplasia by ORAI1 in mouse skin ...17
3. UVB-induced TSLP and COX-2 upregulation by ORAI1 in mouse 
skin.............................................................................................19
4. UVB-induced ORAI and COX-2 upregulation by ORAI1 in 
HaCaT ........................................................................................21
IV. DISCUSSION..............................................................................24
V. CONCLUSION.............................................................................29
VI. REFERENCES ............................................................................30
ABSTRACT (IN KOREAN)..............................................................38
LIST OF FIGURES
Figure 1. Immunohistochemical staining of ORAI1 in mouse 
skin irradiated with 100 mJ/cm2 of UVB.·········14
Figure 2. Immunohistochemical staining of ORAI1 in mouse 
skin irradiated with 200 mJ/cm2 of UVB.·········15
Figure 3. Westernblotting of ORAI1 protein expression in 
mouse skin irradiated with 100 or 200 mJ/cm2 of 
UVB. ····················································16
Figure 4. Epidermal thickness of UVB-irradiated mouse 
treated with or without ORAI1 inhibitor. ·········18
Figure 5. Quantitative real-time PCR for TSLP in UVB-
irradiated mice treated with or without ORAI1 
inhibitor. ················································20
Figure 6. Quantitative real-time PCR for TSLP in UVB-
irradiated mice treated with or without ORAI1 
inhibitor. ················································20
Figure 7. Quantitative real-time PCR for ORAI1 in UVB-
irradiated HaCaT treated with or without ORAI1 
inhibitor. ················································22
Figure 8. Quantitative real-time PCR for COX-2 in UVB-
irradiated HaCaT treated with or without ORAI1 
inhibitor. ················································23
1Abstract
The effects of UVB on ORAI1 channel and the role of ORAI1
channel on the UVB-induced epidermal hyperplasia and
upregulation of TSLP and COX-2
Seung Joon Oh
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Seung Hun Lee)
Epidermal keratinocytes, components of the outermost skin layer, are always 
exposed to the ultraviolet (UV) light from the sun. UV radiation induces a 
number of adverse biological effects, including inflammation and cancer. UV 
irradiation activates numerous signaling pathways that alter transcription 
including keratinocyte proliferation via activation of epidermal growth factor 
receptor (EGFR) augments, inflammation, and carcinogenesis. 
Calcium (Ca2+) signaling is a major second messenger essential to a variety 
of intracellular signaling pathways. ORAI1 and its sensor STIM1 are 
2activated by endoplasmic reticulum (ER) stress and induce Ca2+ influx from 
the extracellular medium, which is named store-operated calcium entry 
(SOCE). 
Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine belonging to 
the Th2 cytokine family which has a key role in the initiation and 
maintenance of allergic inflammatory diseases. Cyclooxygenase-2 (COX-2)
increases production of PGE2 known to promote skin carcinogenesis.
At present, nothing is known about the functional role of ORAI1 channel 
for UV induced biological effects in the skin. In this paper we have shown 
that UVB induces the expression of ORAI1. In addition, using topical 
application of ORAI1 inhibitor, we have confirmed functional roles of 
ORAI1 in UVB-induced change such as epithelial proliferation, TSLP 
induction and cyclooxygenase 2 (COX-2) induction. Thus, this study 
revealed that ORAI1 is a central modulator of the UV response of the 
skin that regulates cell proliferation, inflammation and even 
carcinogenesis. ORAI1 may represent a new therapeutic target for 
negative effects of UVB.
Key words : ultraviolet (UV) light, calcium, ORAI1, STIM1, cyclooxygenase 2 
(COX-2), thymic stromal lymphopoietin (TSLP)
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I. INTRODUCTION
The skin is the organ that acts as a barrier between the outer and inner 
environments of the body. Skin is exposed not only to a variety of physical, 
chemical, and thermal threats from the outside but also to inside endogenous 
stimuli. The integrity of differentiation process of keratinocytes (KCs) is 
critical for skin barrier function. Calcium (Ca2+) signals are known to control 
keratinocyte proliferation and differentiation.1,2 The marked Ca2+ gradient
presents in the epidermis, higher in the stratum granulosum than in the basal 
layer.3 This Ca2+ gradient is very important for keratinocyte proliferation, 
4differentiation and barrier homeostatsis. Ca2+ pumps and channels play an 
important role in matinining this Ca2+ gradient and barrier homeostasis.4
Defects of Ca2+ pumps can cause skin diseases such as Darier disease and
Hailey-Hailey disease involving abnormal keratinocyte differentiation and 
barrier dysfunction.5,6
ORAI1 channel is one of the well-known Ca2+ selective ion channel.7
Reduction in endoplasmic reticulum (ER) Ca2+ is sensed by calcium sensor 
STIM1, that then transactivates plasma membrane Ca2+ channel ORAI1
channel and induces Ca2+ influx from the extracellular medium, which is 
named store-operated calcium entry (SOCE).8,9 SOCE is a major Ca2+ influx 
pathway in most non-excitable cells and involved in cell proliferation and 
differentiation processes.10,11 Epidermal growth factor (EGF) signaling in 
keratinocytes also involves SOCE mediated by ORAI1 channels.7 Recently, 
the topical application of ORAI1 activator was reported to reverse the 
epidermal atrophy induced by corticosteroids in mice.12 In addition, ORAI1
channel, signaling via the NFAT pathway, regulates thymic stromal 
lymphopoietin (TSLP) which is a cytokine released from keratinocytes and 
plays an important role in the pathogenesis of atopic dermatitis.13,14 TSLP 
evoked sensory neurons triggering pruritus and stimulates skin-resident group 
2 innate lymphoid cells to induce interleukin (IL) -5 and IL-13 expression 
leading to eosinophil recruitment and inflammation.15 ORAI1-mediated NFκB 
activation is also reported to play a role in the regulation of cyclooxygenase-2 
5(COX-2).16 Prostaglandin, which is an important pro-inflammatory molecule 
involved in the pathogenesis of a variety of diseases, is metabolized from 
arachidonic acid by the COX-2.16
Exposure of skin to ultraviolet (UV) radiation from the sun induces a number 
of adverse biological effects, including inflammation and carcinogenesis. UV 
irradiation activates numerous signaling pathways that alter transcription. UV-
induced activation of EGF receptor augments keratinocyte proliferation and 
suppresses apoptosis, leading to epidermal hyperplasia, associated with 
increased G1 cyclin expression and suppression of cyclin dependent kinase 
(CDK).17 In contrast, UVB also induces an immediate reactive oxygen species 
(ROS) generation that resulted in emptying of ER Ca2+ stores inducing ER 
stress and activation of RNA dependent protein kinase like ER kinase 
(PERK)-phosphorylated eukaryotic initiation factor 2α (peIF2α)-C/EBP-
homologous protein (CHOP) pathway.18 CHOP plays a convergent role in 
unfolded protein response (UPR) and has been identified as one of the most 
important mediators of ER stress induced apoptosis.19 UV exposure also 
causes inflammatory responses in the skin. UV radiation activates the 
transcription factor NFκB, which stimulates transcription of pro-inflammatory 
cytokine genes, such as IL-1β, TNF-α, IL-6, and IL-8.20 UVB also induces 
TSLP expression through a HIF-1α-dependent mechanism.21 Another 
inflammatory molecule, COX-2 is induced by UV exposure through NFκB 
signaling.22
6Those previous reports imply the distinct possibility that ORAI1-mediated 
Ca2+ influx could also be involved in the regulation of cellular functions in 
particular under stress conditions such as UV-irradiation. At present, nothing 
is known about the functional role of ORAI1 channels for UV induced 
biological effects in the skin. The aim of this study was to determine the
effects of UVB on the expression of ORAI1 and its functional role in UVB-
induced epidermal hyperplasia, and TSLP and COX-2 upregulation.
7II. MATERIALS AND METHODS
1. Cell culture and treatments
The immortalized human keratinocytes cell line, HaCaT (Cell Lines Service 
GmbH, Germany) was grown in DMEM medium, supplemented with 10% 
fetal bovine serum, 200 U/mL penicillin and 270 mg/mL streptomycin 
(Sigma–Aldrich, St. Louis, MO, USA). The cells were maintained in a 
humidified chamber at 37.8 °C and 5% CO2. 
Before UVB exposure, HaCaT cells were seeded with 4×105 cells/well on a 
35-mm dish and were incubated for 2 hours with 10 µM of GSK-7975A 
(AOBIOUS) or 1 µM of BTP2 (Sigma) which were reported to block the 
ORAI1 channel.
For UVB exposure, HaCaT cells (about 80% confluence) were washed with 
phosphate buffered saline (PBS) twice and exposed to UVB irradiation (Bio-
Sun; Vilber lourmet). The total energy dose of UVB irradiation was 30 
mJ/cm2. After UVB exposure, cells were harvested up to 24 hours, and 
quantitative real-time polymerase chain reaction (qRT-PCR) was done.
82. Mice and treatments
Female hairless mice (SKH1/Hr), 6-7 weeks of age, were purchased from 
Orient Bio (Seoul, Korea). All animal experiments described were conducted 
in accord with accepted with standards of humane animal care and approved 
by the local animal research committee. The mice were killed and their skin
samples were taken at 30 min, 4 hours, 24 hours and 72 hours after UVB 
irradiation. Each group has 2 mice.
A UVB lamp (PL-S 9W/01/2P; Philips, Warszawa, Poland) with a 280- to 
320-nm emission was used. The UVB fluence rate was simultaneously 
measured and integrated using a radiometer (XD-9521 from Daavlin) placed 
at the same distance from the UVB source. A dose of 100 mJ/cm2 or 200
mJ/cm2 was used in the study, because this dose yielded the optimal effect 
without significantly affecting cell viability. One minimal erythema dose 
(MED) equals approximately 80 mJ/cm2 in this species.23
Mice were treated by a topical application (100 µl) of ORAI1 inhibitor,
BTP2 (Sigma) 1 µM dissolved in ethanol solvent. In the morning and the 
evening (8 hours apart) daily ethanol (control) was applied on the right side of 
back and BTP2 was applied on the left side of back immediately after UVB 
irradiation.
93. Quantification of epidermal thickness and hyperplasia
Thickness of the epidermal nucleated cell layers from the epidermal–dermal 
junction to the distal edge of the stratum granulosum was measured in at least 
five randomly selected regions from each hematoxylin and eosin stained slide 
using ocular and stage micrometers. For quantification of epidermal
hyperplasia following UV exposure, the number of nucleated epidermal cell 
layers was counted in the same regions. Measurements were performed with 
the investigator blinded as to the identity of the samples.
4. Immunohistochemical staining
Skin sections from mouse were either cryoconserved by including in OCT 
(Sakura Finetek Europe, Alphen aan den Rijn, The Neherlands) or dehydrated 
and embedded in paraffin. ORAI1 immunostainings were performed on 
paraffin-embedded sections. Sections were rehydrated, antigens were 
unmasked by boiling sections in 10mM citrate buffer or 1 nM EDTA, and 
then stained with anti-ORAI1 antibody (Sigma, 08264, Carlsbad, CA). An 
anti-rabbit biotinylated antibody was used as secondary antibody to detect 
ORAI1. Sections were then incubated with a ready-to-use streptavidin-HRP 
solution (DAKO) and revealed with 3,39-diaminobenzidine (Sigma). Images 
were acquired with a Zeiss microscope (Jena, Germany). To avoid irrelevant 
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variations of the staining intensity in the immunohistochemistry, all 
conditions were stained with the same solutions and timing. 
5. qRT-PCR for mRNA expression
Mouse: The epidermis was separated from the dermis by scraping the skin 
on ice with a size 21 scalpel blade and then homogenized with a polytron in 
buffer (50 mM Tris, pH 7.4, 1% Tween-20) containing 100 mg/mL 
phenylmethylsulfonyl fuoride and a protease inhibitor cocktail (Roche 
Molecular Biochemicals, Indianapolis, IN). Total RNA was extracted using 
the TRIzol Reagent (Invitrogen, Carlsbad, CA), following the manufacturer’s 
protocol. Reverse-transcription reactions were performed using 1 mg total 
RNA. The cDNA samples were analyzed for TSLP (Mm01157588_m1) and 
COX-2 (Mm00478374_m1).
HaCaT: For the relative mRNA expression analysis of selected genes, total 
RNA was isolated TRIzol (Invitrogen), according to the manufacturer's 
instructions. The RNA was qua  ntified using a NanoDrop 
spectrophotometer (NanoDrop Technologies, Rockland, DE, USA). RNA (4 
μg) was reverse transcribed into cDNA using SuperScript III reverse 
transcriptase (Invitrogen), and aliquots were kept at −20°C. qRT–PCR was 
performed using an ABI 7500 Fast Real-Time PCR System with 
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commercially available TaqMan site-specific primers and probes (Applied 
Biosystems, Foster City, CA, USA). The cDNA samples were analyzed for 
ORAI1 (Hs00375481_m1), TSLP (Hs00263639_m1), and COX-2
(Hs00153133_m1). The results were normalized to the glyceraldehyde 3-
phosphate dehydrogenase levels. The data were analyzed using 7500 Fast 
System SDS Software version 1.3.1 (Applied Biosystems). All of the data 
were obtained from more than two independent experiments carried out in 
triplicate.
6. Western blotting
Total protein was extracted from epidermal extracts with lysis buffer (50
mM Tris, 5 mM EDTA, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 
1mM sodium orthovanadate, 100 mg/ml phenylmethanesulfonylfluoride, and 
protease inhibitors). Protein concentrations were determined with the
bicinchoninic acid protein assay reagent (Pierce, Rockford, IL) using BSA as 
the standard. Protein lysates (30 mg) were resolved by 10–12% SDS–PAGE 
and transferred to polyvinylidene difluoride membranes (Millipore). After 
blocking, the polyvinylidene difluoride membranes were incubated overnight 
with anti-ORAI1 antibody (Sigma, 08264, Carlsbad, CA) on a shaker at 4°C. 
After extensive washing, the membranes were incubated with secondary 
peroxidase-linked IgG (1:5,000, Abcam) for 1 hour. After washing three times 
12
for 10 minutes with Tris-buffered saline with Tween 20 at room temperature, 
the immunoreactivity was detected by enhanced chemiluminescence (ECL kit, 
Amersham Pharmacia Biotech, Piscataway, NJ).
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III. Results
1. Upregulation of ORAI1 expression by UVB irradiation in murine 
epidermis
To determine whether UVB induces ORAI1 expression, mice were irradiated 
with different UVB doses (0, 100, and 200 mJ/cm2) and incubated up to 72
hours. ORAI1 expression was increased 1 day after 100 or 200 mJ/cm2 of 
UVB irradiation (Figure 1,2). It showed time-dependent increases in ORAI1 
expression. In addition, 200 mJ/cm2 of UVB showed more prominent staining 
results compared with 100 mJ/cm2 of UVB. To confirm the levels of ORAI1
protein expression induced by UVB in epidermis, we used a western blotting. 
ORAI1 protein expression was increased in epidermis irradiated with 100
mJ/cm2 and 200 mJ/cm2 of UVB compared with the control (Figure 3). It also 
showed time-dependent increases in ORAI1 expression. And similary to 
immunohistochemical staining result, 200 mJ/cm2 of UVB showed more 
increased protein levels than 100 mJ/cm2 of UVB
14
Figure 1. ORAI1 immunohistochemical staining after 100 mJ/cm2 of UVB 
irradiation. (A) ORAI1 expression in the untreated mouse skin. ORAI1 was 
mostly expressed in basal layer as previous reports. (B-E) ORAI1 level is 
increased at 1 day and 3 days after UVB irradiation compared with untreated 
control. Original magnification: X200. 
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Figure 2. ORAI1 immunohistochemical staining after 200 mJ/cm2 of UVB 
irradiation. (A) ORAI1 expression in the untreated mouse skin. (B-E) ORAI1 
level is increased from 4 hours after UVB irradiation compared with untreated 
control. Original magnification: X200.
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Figure 3. Western blotting of ORAI1 reveled time-dependent and dose-
dependent increases in ORAI1 protein expression.
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2. Mediation of UVB-induced epidermal hyperplasia by ORAI1 in murine 
epidermis
As 100 mJ/cm2 UVB irradiation showed more epidermal hyperplasia, this 
amount was selected for this experiment. UVB is reported to induce epidermal 
hyperplasia through EGF receptor activation. On the basis of previous reports, 
the thickness of epidermis was increased at 3 days after UVB irradiation 
(Figure 4A-D). To confirm the role of ORAI1, we applied BTP2 on a half of 
back twice a day daily immediately after UVB irradiation. BTP2 attenuates 
UVB-induced epidermal hyperplasia in mice skin (Figure 4E). These findings
suggest that UVB-induced ORAI1 activation may increase the proliferation of 
keratinocyte in murine epidermis.
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Figure 4. Epidermal thickness of UVB-irradiated mice treated with or without 
ORAI1 inhibitor, BTP2. (A) Epidermis of untreated mouse skin. (B,C) There 
is no difference of epidermal thickness between mice treated or not treated 
with BTP2 at a day after UVB irradiation. (D,E) UVB induced epidermal 
hyperplasia (D) and BTP2 suppressed UVB-induced epidermal hyperplasia (E)
at 3 days. Original magnification: X200.
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3. Mediation of UVB-induced TSLP and COX-2 upregulation by ORAI1 
in murine epidermis
As 200 mJ/cm2 UVB irradiation showed more prominent results, this amount 
was selected for subsequent experiments. To definitively demonstrate the role 
of ORAI1 in TSLP induction, we analyzed the effect of ORAI1 on TSLP 
expression by applying BTP2 on a half of back. At 3 days after UVB 
irradiation, TSLP upregulation by UVB was attenuated on the BTP2-treated 
flank compared to the contralateral, non-treated flank (Figure 5). Thus, the 
effect of UVB on TSLP upregulation is mediated by ORAI1 activation.
In addition, at 1 day after UVB irradiation, COX-2 upregulation by UVB 
was delayed on the BTP2-treated flank compared to the contralateral, non-
treated flank (Figure 6). Taken together, these results demonstrate that the role 
of ORAI1 in UVB-induced harmful effects on epidermis.
20
Figure 5. TSLP mRNA was upregulated by UVB irradiation. BTP2 
attenuated TSLP upregulation 3 days after UVB irradiation. 
Figure 6. COX-2 mRNA was upregulated by UVB. BTP2 attenuated COX-2 
upregulation 1 day after UVB irradiation.
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4. Mediation of UVB-induced ORAI1 and COX-2 upregulation by ORAI1 
in HaCaT
To confirm the upregulation of ORAI1 by UVB-irradiation and the role of 
ORAI1, we conducted in vitro experiments with HaCaT. To clarify the 
specific role of ORAI1, we used two ORAI1 inhibitors, whether GSK-7975A 
or BTP2. At 1 hour after UVB irradiation, ORAI1 mRNA expression was 
increased about 2-folds (Figure 7). And we found both inhibitors reversed 
upregulation of ORAI1 mRNA expression. In the same manner, COX-2 
mRNA expression was increased about 4-folds and both inhibitors reversed 
upregulation of COX-2 mRNA expression (Figure 8). However, TSLP failed 
to show upregulation (Data are not shown). Although we used a 30 mJ/cm2 of 
UVB, HaCaT lost their viability at 24 hours after UVB irradiation. Thus, 
these results confirm the role of ORAI1 in UVB-induced effects on epidermis.
22
Figure 7. Quantitative real-time PCR for ORAI1 in UVB-irradiated HaCaT 
treated with or without ORAI1 inhibitor (GSK: GSK-7975A, BTP: BTP2). 1 
hour after UVB exposure, HaCaT showed upregulated ORAI1 mRNA 
expression. UVB-induced ORAI1 upregulation is reversed by either GSK or 
BTP.
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Figure 8. Quantitative real-time PCR for COX-2 in UVB-irradiated HaCaT  
treated with or without ORAI1 inhibitor (GSK: GSK-7975A, BTP: BTP2). 1 
hour after UVB exposure, HaCaT showed upregulated COX-2 mRNA 
expression. UVB-induced COX-2 upregulation is reversed by either GSK or 
BTP.
24
IV. Discussion
UVB radiation is well known to induce ER stress and activate UPR24. UVB
damages the human skin, causing premature aging and severe skin 
pathologies, including cancer.25 Previous study reported ORAI1 as a main 
player in UV-induced melanogenesis.26 STIM2-regulated ORAI1 was
identified as one of the major SOCE pathways in primary melanocytes, being
activated by endothelin-1 which can be released by UVB irradiation.26
However, our study is the first study which shows direct effects of UVB on 
the expression and function of ORAI1 in keratinocytes. In mouse skin,
ORAI1 level is increased after UVB irradiation of 100 or 200 mJ/cm2. ORAI1
expression showed time-dependent and dose-dependent increase. As reported
previously, the UVB irradiated epidermis of skin was slightly thickened 
compared with intact mice skin.17 The proliferative effects of UV17 and of 
ORAI112 in the skin have been independently documented. We showed
ORAI1 inhibitor attenuated UVB-induced epidermal hyperplasia. Thus, 
present study showed UVB-induced epidermal hyperplasia is dependent on 
ORAI1. ORAI1 might suppress UVB-induced apoptosis although the anti-
apoptotic role of ORAI1 and STIM1 has been reported controversially.27,28
TSLP is an IL-7-like cytokine belonging to the Th2 cytokine family.29 TSLP 
acts as a master switch for Th2 immune responses and may have a key role in 
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the initiation and maintenance of allergic inflammatory diseases, including
AD.30 Recent studies have shown that UVB radiation exposure increases The 
present study shows that UVB irradiation can induce TSLP expression via 
ORAI1 signaling, too. ORAI1 mediates NFAT-dependent cytokine expression 
during immune cell activation and the loss of function mutations in ORAI1
and STIM1 leads to severe combined immunodeficiencies in patients.9,31
ORAI1 may play more general role in the pathogenesis of inflammatory 
disease. Although a role for the ORAI1 in atopic dermatitis had not been 
studied, SNPs in the ORAI1 gene have been linked to susceptibility to atopic 
disease in humans.32 Thus, ORAI1 may represent a new therapeutic target for 
inflammatory skin disease such as sun exposure-related dermatitis or atopic 
dermatitis.
COX-2 is a key inducible enzyme known to be involved in producing 
prostaglandins and other eicosanoids in the inflammatory reaction. COX-2 
increases production of PGE2 known to modulate cell proliferation, cell death, 
and tumor invasion in many types of cancer. PGE2 production by UV induced 
COX-2 is thought to promote skin carcinogenesis, as well as contribute to 
even the earliest stages of UV-induced skin damage.33 Topical and systemic
treatment with celecoxib, a COX-2-selective inhibitor has also been shown to 
inhibit UV-induced skin tumorigenesis.34-36 Thus, the present findings suggest 
that ORAI1 may be involved in the pathogenesis of UVB-mediated skin 
cancer through COX-2 regulation. This assumption is supported by reports 
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showing upregulation of ORAI and STIM proteins in cancer growth, 
migration, and metastasis.37-40 Findings from our present study show that 
topical treatment of BTP2 immediately after UV exposure inhibited UV-
induced epidermal hyperplasia and upregulation of TSLP and COX-2. 
Therefore, our results suggest that suppression of UV induced changes by 
BTP2 may prevent UV-induced skin damage and inflammation.
ROS such as superoxide anion (O2-) and hydrogen peroxide (H2O2) play a 
role in physiological and pathophysiological processes through oxidizing 
proteins, lipids and polynucleotides.41 Increasing evidence indicates that ROS
and Ca2+ interacts together to finely tune the homeostasis. Ca2+ is released 
from ER mediated by ryanodine recptors (RyR) and 1,4,5-inositol-
triphosphate receptors (IP3R). It has been reported that ROS enhances RyR 
and IP3-induced Ca
2+ release from endo/sarcoplasmic reticulum (ER/SR).42
Not only IP3R, but also RyR are expressed in epidermal keratinocytes.
43 In 
addition, ROS inhibits Ca2+ transport by ER/SR Ca2+-ATPases (SERCA) 
which replenish ER/SR Ca2+ stores in smooth muscle cells.41 These reports 
suggest that UV-induced ROS may activate ORAI1 through ER calcium 
depletion.
As we could not find any references with topical treatment of BTP2 to the 
skin, we decided the concentration of BTP2 considering absorption of the skin. 
In our experiments, applying twice a day with 100 µl of BTP2 1 µM dissolved 
27
in ethanol solvent was enough to inhibit ORAI1 activation. UVB-induced skin 
damage may let BTP2 to be absorbed more easily through epidermis. Further 
study will be needed to clarify the proper dose and efficient form of BTP2.
Human keratinocytes express not only ORAI1, but also TRP which are non-
selective ion channels with only a very modest Ca2+ selectivity. TRP has been 
reported to interact with STIM/ORAI. ORAI and TRP interfere with each 
other in skin barrier formation, atopic dermatitis pathogenesis, and even 
melanogensis.11,26,32,44,45 TRPM1 and TRPA1 has been reported to be 
associated with UV radiation, but they are mainly expressed in melanocytes, 
not keratinocytes.46,47 Among TRP expressed in keratinocytes, TRPV1 was 
reported to be associated with UV-induced cutaneous changes. Topical 
application of TRPV1 blocker reversed UV-induced epidermal hyperplasia, 
and upregulation of metalloproteinases, pro-inflammatory cytokines, and 
COX-2.20 In addition, TRPV1 expression is increased in photoaged human 
skin.48 Taken together, STIM1/ORAI1 may interact with other TRP channels 
such as TRPV1 in UV-induced cutaneous response.
Hair loss, thinner epidermis and alopecia have been reported in mice lacking 
ORAI1.49 In addition, ectodermal dysplasia with anhydrosis was observed in 
very few human patients with mutations in ORAI1 and STIM1 genes (severe 
combined immunodeficiency patients).50 These previous results clearly 
suggest ORAI1 is an important calcium channel regulates skin homeostasis. 
28
However, it was unknown whether UV-induced keratinocyte associated 
changes are regulated by ORAI1 until this study. Although it has not been
reported, patients with mutation in ORAI1 and STIM1 genes may have 
different sensitivity to UVB. In future, a comparison of UV-induced change in 
humans with defective ORAI and/or STIM function with healthy controls 
could provide further evidence for the role of ORAI1 and Ca2+ signaling in 
UV-induced changes.
29
V. Conclusion
This research demonstrates that ORAI1 channel is a major regulator of the 
UVB response in skin. Keratinocyte proliferation and epidermal hyperplasia 
following UVB exposure were dependent on ORAI1 activation. In addition, 
the present findings suggest ORAI1 plays more general role in UVB-induced 
inflammation or carcinogenesis through TSLP or COX-2.
In conclusion, this study confirmed that ORAI1 is a central modulator of the 
UVB response of the skin that regulates cell proliferation, inflammation and
even carcinogenesis. Therefore, we suggest that ORAI1 inhibitors may 
prevent UV-induced skin damage and might be used for keeping healthy skin 
avoiding sun damage.
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ABSTRACT (IN KOREAN)
자외선B가 ORAI1 채널에 미치는 영향과 자외선 B로 인한
표피증식 및 TSLP, COX-2 상향조절에서의 ORAI1 채널의 역할
<지도교수 이승헌>
연세대학교 대학원 의학과
오승준
피부는 외부 환경으로부터 보호막 역할을 하는 중요한 기관이다. 
이러한 피부는 항상 태양광선으로부터 나오는 자외선B에 노출되게
된다. 자외선B 광선은 여러가지 생물학적 반응을 유발하게 되는데
특히 표피성장인자 (epidermal growth factor receptor)의 활성화를 통한
각질세포의 증식이나 염증반응, 악성종양형성 등이 대표적인
것들이다.
칼슘 신호는 대표적인 이차 신호 전달 체계로써 소포체의
스트레스 (endoplasmic reticulum stress)를 감지하는 STIM1과 이 것에
의해 활성화되는 ORAI1 칼슘채널은 세포막 외부로부터 세포
내부로 칼슘을 운송하는 역할을 한다. 이 칼슘의 흐름을 store-
operated calcium entry(SOCE)라고 부른다. Thymic stromal lymphopoietin 
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(TSLP)는 Th2 cytokine family에 속해있는 IL-7-like cytokine으로써
알러지성 염증 질환의 발현과 유지에서 중요한 역할을 한다. 
Cyclooxygenase 2 (COX-2)는 프로스타글랜딘 E2의 생성을 통해
악성종양형성을 촉진시키는 것으로 알려진 물질이다.
아직까지 자외선B에 의한 ORAI1 채널의 변화와 그 역할에 대한
연구는 거의 없었다. 따라서 본 연구의 목적은 자외선B가 ORAI1
채널에 미치는 영향과 ORAI1 채널의 역할에 대하여 알아보고자
하였다. 우리는 생쥐모델을 이용하여 자외선B가 ORAI1 채널을
발현시킨다는 것을 알아냈다. 또한 ORAI1 채널의 억제제를
국소도포하는 방법을 이용하여 ORAI1 채널이 자외선 B에 의한
표피증식 및 TSLP, COX-2의 상향 조절에 관여한다는 사실을
증명하였다. 또한 HaCaT을 이용한 세포 실험으로 비슷한 결과를
얻을 수 있었다. 결론적으로 이번 연구를 통해서 ORAI1 채널이
자외선B 반응의 중요한 조절자라는 사실을 알게 되었으며 이를
통해 향후 ORAI1 채널을 표적으로 자외선B에 의한 악영향을
예방하고 감소하는 새로운 약물의 발전도 기대할 수 있을 것이다. 
핵심되는 말: 자외선B, 칼슘, ORAI1, STIM1, cyclooxygenase 2 
(COX-2), thymic stromal lymphopoietin (TSLP)
